• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析原发性根治性切除术后肝癌不可移植复发的危险因素。

Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.

机构信息

Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Ann Surg Oncol. 2013 Aug;20(8):2526-33. doi: 10.1245/s10434-013-2940-7. Epub 2013 Mar 16.

DOI:10.1245/s10434-013-2940-7
PMID:23504121
Abstract

PURPOSE

To determine the prognostic factors that predict recurrence of hepatocellular carcinoma (HCC) exceeding the University of California at San Francisco (UCSF) criteria after primary resection.

METHODS

HCC patients who underwent curative liver resections between 2001 and 2007 and who were within the UCSF criteria (n = 716) were examined. Independent prognostic factors were examined by the Cox proportional hazard model.

RESULTS

A total of 285 patients (39.8 %) developed recurrences. Of the patients who developed recurrences, 180 had HCC still within the UCSF criteria (63.2 %), and 105 developed HCC beyond this criteria (36.8 %). Among the population with primary transplantable HCC, patients with larger primary tumor sizes, serum α-fetoprotein (AFP) levels over 400 ng/mL, satellite nodules, vascular invasion, or undifferentiated HCC had a risk of untransplantable recurrence, as shown by univariate analysis. In multivariate analysis, undifferentiated HCC and vascular invasion were identified as the significant predictors with adjusted hazard ratios of 9.25 [95 % confidence interval (CI) 2.13-40.21] and 2.19 (95 % CI 1.34-3.58), respectively. When only preoperative factors were considered in multivariate analysis, primary tumor size and serum AFP levels over 400 ng/mL were identified as significant predictors with adjusted hazard ratios of 1.24 (95 % CI 1.07-1.45) and 1.72 (95 % CI 1.05-2.82), respectively.

CONCLUSIONS

For primary HCC patients within the UCSF criteria, larger tumor sizes and AFP levels over 400 ng/mL were associated with postresection recurrence of HCC exceeding the UCSF criteria. Because these are clearly markers for aggressive tumor biology, whether early primary transplant will alter the aggressive tumor behaviors warrant further investigation.

摘要

目的

确定预测加利福尼亚大学旧金山分校(UCSF)标准内原发性切除术后肝细胞癌(HCC)复发的预后因素。

方法

检查了 2001 年至 2007 年间接受根治性肝切除术且符合 UCSF 标准的 HCC 患者(n=716)。使用 Cox 比例风险模型检查独立的预后因素。

结果

共有 285 例患者(39.8%)发生了复发。在发生复发的患者中,180 例 HCC 仍在 UCSF 标准内(63.2%),105 例 HCC 超出此标准(36.8%)。在原发性可移植 HCC 人群中,原发性肿瘤较大、血清α-胎蛋白(AFP)水平超过 400ng/mL、卫星结节、血管侵犯或未分化 HCC 的患者,通过单因素分析显示出不可移植性复发的风险。多因素分析显示,未分化 HCC 和血管侵犯是有意义的预测因子,调整后的危险比分别为 9.25(95%可信区间:2.13-40.21)和 2.19(95%可信区间:1.34-3.58)。当仅在多因素分析中考虑术前因素时,原发性肿瘤大小和血清 AFP 水平超过 400ng/mL 被确定为有意义的预测因子,调整后的危险比分别为 1.24(95%可信区间:1.07-1.45)和 1.72(95%可信区间:1.05-2.82)。

结论

对于符合 UCSF 标准的原发性 HCC 患者,较大的肿瘤大小和 AFP 水平超过 400ng/mL 与 UCSF 标准内 HCC 切除术后复发相关。因为这些显然是侵袭性肿瘤生物学的标志物,早期进行原发性移植是否会改变侵袭性肿瘤行为值得进一步研究。

相似文献

1
Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.分析原发性根治性切除术后肝癌不可移植复发的危险因素。
Ann Surg Oncol. 2013 Aug;20(8):2526-33. doi: 10.1245/s10434-013-2940-7. Epub 2013 Mar 16.
2
Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.在接受活体肝移植的肝细胞癌患者中,较年轻的年龄和存在大血管侵犯是与无病生存期不佳相关的独立显著因素。
Transplant Proc. 2012 Mar;44(2):516-9. doi: 10.1016/j.transproceed.2012.01.032.
3
Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.肿瘤生长速率可预测超出米兰或加州大学旧金山分校标准的患者肝移植后肝细胞癌的复发情况。
Transplant Proc. 2011 Dec;43(10):3813-8. doi: 10.1016/j.transproceed.2011.09.043.
4
Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.肿瘤数目和大小均不是选择肝癌患者进行肝移植的充分标准。
Ann Surg Oncol. 2012 Jun;19(6):2020-6. doi: 10.1245/s10434-011-2170-9. Epub 2011 Dec 17.
5
A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.一种新型预后列线图可准确预测肝移植后肝细胞癌复发:对865例连续肝移植受者的分析
J Am Coll Surg. 2015 Apr;220(4):416-27. doi: 10.1016/j.jamcollsurg.2014.12.025. Epub 2014 Dec 27.
6
Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.第 5 节:进一步扩大活体肝移植中 HCC 的标准:何时不移植:SNUH 经验。
Transplantation. 2014 Apr 27;97 Suppl 8:S20-3. doi: 10.1097/01.tp.0000446269.20934.d3.
7
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.肝癌肝移植:包含甲胎蛋白的模型可改善米兰标准的性能。
Gastroenterology. 2012 Oct;143(4):986-94.e3; quiz e14-5. doi: 10.1053/j.gastro.2012.05.052. Epub 2012 Jun 29.
8
Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.检测外周血中表达甲胎蛋白信使核糖核酸的细胞以预测活体供肝移植后肝癌复发情况
Transpl Int. 2007 Jul;20(7):576-82. doi: 10.1111/j.1432-2277.2007.00480.x. Epub 2007 Apr 8.
9
A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.一种利用血清甲胎蛋白水平的修订评分系统,以扩大肝细胞癌活体供体移植的候选者范围。
Surgery. 2007 May;141(5):598-609. doi: 10.1016/j.surg.2006.11.006. Epub 2007 Mar 23.
10
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.复发性肝细胞癌患者再次肝切除术的选择标准。
Ann Surg. 2003 Nov;238(5):703-10. doi: 10.1097/01.sla.0000094549.11754.e6.

引用本文的文献

1
Editorial: Transplant Oncology of Liver Malignancies.社论:肝脏恶性肿瘤的移植肿瘤学
Front Surg. 2022 Jan 5;8:811223. doi: 10.3389/fsurg.2021.811223. eCollection 2021.
2
Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.高危复发性肝细胞癌的预防性肝移植
World J Hepatol. 2016 Nov 8;8(31):1309-1317. doi: 10.4254/wjh.v8.i31.1309.
3
The role of liver transplantation or resection for patients with early hepatocellular carcinoma.肝移植或肝切除在早期肝细胞癌患者中的作用。
Tumour Biol. 2016 Mar;37(3):4193-201. doi: 10.1007/s13277-015-4243-z. Epub 2015 Oct 22.
4
Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.肝细胞癌的多学科视角:太平洋西北地区的经验
World J Hepatol. 2015 Jun 18;7(11):1460-83. doi: 10.4254/wjh.v7.i11.1460.
5
Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis.癌症干细胞标志物CD133表达在肝细胞癌中的临床病理意义及预后价值:一项荟萃分析
Tumour Biol. 2015 Sep;36(10):7623-30. doi: 10.1007/s13277-015-3487-y. Epub 2015 Apr 29.
6
Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review).抗病毒治疗在根治性切除术后乙肝病毒相关性肝细胞癌降低复发率及提高生存率中的作用(综述)
Oncol Lett. 2015 Feb;9(2):527-534. doi: 10.3892/ol.2014.2727. Epub 2014 Nov 21.
7
Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection.根治性切除术后孤立性肝细胞癌早期和晚期肝内复发的危险因素及管理
HPB (Oxford). 2015 May;17(5):422-7. doi: 10.1111/hpb.12367. Epub 2014 Nov 24.
8
Prognostic value of serum γ-glutamyl transferase in unresectable hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization combined with conformal radiotherapy.血清γ-谷氨酰转移酶在经动脉化疗栓塞联合适形放疗治疗的不可切除肝细胞癌患者中的预后价值
Oncol Lett. 2014 Nov;8(5):2298-2304. doi: 10.3892/ol.2014.2456. Epub 2014 Aug 19.
9
Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma.癌症干细胞标志物与肝细胞癌的早期复发和生存相关。
World J Gastroenterol. 2014 Feb 28;20(8):2098-106. doi: 10.3748/wjg.v20.i8.2098.